These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18294927)
1. Potential and limits of in silico target discovery - Case study of the search for new antimalarial chemotherapeutic targets. Saïdani N; Grando D; Valadié H; Bastien O; Maréchal E Infect Genet Evol; 2009 May; 9(3):359-67. PubMed ID: 18294927 [TBL] [Abstract][Full Text] [Related]
2. Histone as future drug target for malaria. Rawat DS; Lumb V; Sharma YD; Pasha ST; Singh G J Commun Dis; 2007 Jun; 39(2):119-28. PubMed ID: 18338692 [TBL] [Abstract][Full Text] [Related]
3. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Na-Bangchang K; Karbwang J Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319 [TBL] [Abstract][Full Text] [Related]
4. Novel molecular targets for antimalarial chemotherapy. Jana S; Paliwal J Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102 [TBL] [Abstract][Full Text] [Related]
5. Novel molecular targets for antimalarial drug development. Sahu NK; Sahu S; Kohli DV Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458 [TBL] [Abstract][Full Text] [Related]
6. Exploring functional genomics for drug target and therapeutics discovery in Plasmodia. Birkholtz L; van Brummelen AC; Clark K; Niemand J; Maréchal E; Llinás M; Louw AI Acta Trop; 2008 Feb; 105(2):113-23. PubMed ID: 18083131 [TBL] [Abstract][Full Text] [Related]
7. Target discovery from data mining approaches. Yang Y; Adelstein SJ; Kassis AI Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549 [TBL] [Abstract][Full Text] [Related]
8. Genomics and systems biology in malaria drug discovery. Dharia NV; Chatterjee A; Winzeler EA Curr Opin Investig Drugs; 2010 Feb; 11(2):131-8. PubMed ID: 20112162 [TBL] [Abstract][Full Text] [Related]
9. [Malaria control in the post-genomic era]. Mercereau-Puijalon O Med Trop (Mars); 2003; 63(3):241-4. PubMed ID: 14579459 [TBL] [Abstract][Full Text] [Related]
10. Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico. Fatumo S; Plaimas K; Mallm JP; Schramm G; Adebiyi E; Oswald M; Eils R; König R Infect Genet Evol; 2009 May; 9(3):351-8. PubMed ID: 18313365 [TBL] [Abstract][Full Text] [Related]
11. Druggability of human disease genes. Sakharkar MK; Sakharkar KR; Pervaiz S Int J Biochem Cell Biol; 2007; 39(6):1156-64. PubMed ID: 17446117 [TBL] [Abstract][Full Text] [Related]
12. Malarial kinases: novel targets for in silico approaches to drug discovery. Bullard KM; DeLisle RK; Keenan SM Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473 [TBL] [Abstract][Full Text] [Related]
13. [Malaria research in the post-genomic era]. Mercereau-Puijalon O J Soc Biol; 2004; 198(3):193-7. PubMed ID: 15662935 [TBL] [Abstract][Full Text] [Related]
17. Biotransformation and biocatalysis: roles and applications in the discovery of antimalarials. Chigorimbo-Murefu NT; Njoroge M; Nzila A; Louw S; Masimirembwa C; Chibale K Future Med Chem; 2012 Dec; 4(18):2325-36. PubMed ID: 23234554 [TBL] [Abstract][Full Text] [Related]
18. Dark side of the genome: genetic blueprints can hinder as well as speed up medical research. New Sci; 2002 Oct; 176(2364):3. PubMed ID: 12731516 [No Abstract] [Full Text] [Related]
19. Progress in in silico functional genomics: the malaria Metabolic Pathways database. Ginsburg H Trends Parasitol; 2006 Jun; 22(6):238-40. PubMed ID: 16707276 [TBL] [Abstract][Full Text] [Related]
20. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Babiker HA; Hastings IM; Swedberg G Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]